Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
JCI Insight|September 25, 2025
CDK12 regulates cellular metabolism to promote glioblastoma growthJeong-Yeon Mun, Chang Shu, Qiuqiang Gao, et al.
ACS Omega|February 28, 2022
Diisothiocyanate-Derived Mercapturic Acids Are a Promising Partner for Combination Therapies in GlioblastomaPengfei Xu, Mike-Andrew Westhoff, Amina Hadzalic, et al.
International Journal of Cancer|August 16, 2014
RIST: a potent new combination therapy for glioblastomaLisa Nonnenmacher, Mike-Andrew Westhoff, Simone Fulda, et al.
Oncotarget|February 13, 2016
Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivoGeorg Karpel-Massler, Matei A Banu, Chang Shu, et al.
Molecular and Cellular Therapies|June 10, 2015
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapyMike-Andrew Westhoff, Georg Karpel-Massler, Oliver Brühl, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 11, 2014
Artesunate enhances the antiproliferative effect of temozolomide on U87MG and A172 glioblastoma cell linesGeorg Karpel-Massler, Mike-Andrew Westhoff, Richard E Kast, et al.
Cells|July 16, 2020
Inhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model SystemsTrang T T Nguyen, Yiru Zhang, Enyuan Shang, et al.
Molecular Oncology|April 3, 2024
The Alcatraz-Strategy: a roadmap to break the connectivity barrier in malignant brain tumoursMatthias Schneider, Anna-Laura Potthoff, Georg Karpel-Massler, et al.
Plos One|December 23, 2014
PARP inhibition restores extrinsic apoptotic sensitivity in glioblastomaGeorg Karpel-Massler, Fresia Pareja, Pascaline Aimé, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma TherapyMike-Andrew Westhoff, Marie Schuler-Ortoli, Daniela Zerrinius, et al.
Pageof 9